ArticleFrontiers in oncology2018

Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia.

Richard E KastPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.